Top compounds associated with response to KCTD17


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA clofarabine CTRPv2 pan-cancer AAC 0.11 0.0005
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA DBeQ CTRPv2 pan-cancer AAC 0.13 0.0007
mRNA SU11274 CTRPv2 pan-cancer AAC 0.12 0.0009
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.11 0.001
mRNA Gemcitabine gCSI pan-cancer AAC 0.19 0.001
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.097 0.001
mRNA Topotecan CTRPv2 pan-cancer AAC 0.11 0.002
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC 0.12 0.002
Download CSV